Literature DB >> 21622767

Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort.

Arthur G Pratt, Peter J Charles, Muslima Chowdhury, Gillian Wilson, Patrick J Venables, John D Isaacs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21622767     DOI： 10.1136/ard.2010.148197

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?

Authors:  Diederik P C De Rooy; Annemiek Willemze; Bart Mertens; Tom W J Huizinga; Annette H M Van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2011-10-27       Impact factor: 5.156

2.  An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.

Authors:  Jurgen van Heemst; Leendert A Trouw; Leonor Nogueira; Hanna W van Steenbergen; Annette H M van der Helm-van Mil; Cornelia F Allaart; Guy Serre; Rikard Holmdahl; Tom W J Huizinga; René E M Toes; Diane van der Woude
Journal:  Arthritis Res Ther       Date:  2015-10-05       Impact factor: 5.156

3.  Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis.

Authors:  Charlotte Hua; Claire I Daien; Bernard Combe; Robert Landewe
Journal:  RMD Open       Date:  2017-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.